Mike Biologics: Net profit attributable to the parent in the first half of the year decreased by 83.12% year-on-year.

Jin10 reported on July 30 that Mike Biotech announced that the company's operating revenue for the first half of the year was 1.075 billion yuan (RMB), a year-on-year decrease of 15.94%; the net profit attributable to the parent company for the first half of the year was 34.0425 million yuan, a year-on-year decrease of 83.12%; the net cash flow from operating activities was 162 million yuan, a year-on-year decrease of 23.93%.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)